Compare IXHL & RMCO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | IXHL | RMCO |
|---|---|---|
| Founded | 2001 | 2021 |
| Country | Australia | United States |
| Employees | N/A | N/A |
| Industry | | Multi-Sector Companies |
| Sector | | Miscellaneous |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 49.1M | 45.7M |
| IPO Year | N/A | N/A |
| Metric | IXHL | RMCO |
|---|---|---|
| Price | $0.39 | $2.38 |
| Analyst Decision | | Buy |
| Analyst Count | 0 | 1 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | ★ 24.9M | 71.5K |
| Earning Date | 11-14-2025 | 11-13-2025 |
| Dividend Yield | N/A | ★ 0.41% |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | $12,000.00 | ★ $3,798,352.00 |
| Revenue This Year | N/A | $531.90 |
| Revenue Next Year | N/A | $200.00 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | ★ 445.90 |
| 52 Week Low | $0.08 | $0.91 |
| 52 Week High | $2.25 | $4.76 |
| Indicator | IXHL | RMCO |
|---|---|---|
| Relative Strength Index (RSI) | 49.46 | 45.66 |
| Support Level | $0.38 | $2.32 |
| Resistance Level | $0.45 | $2.61 |
| Average True Range (ATR) | 0.04 | 0.28 |
| MACD | 0.00 | 0.02 |
| Stochastic Oscillator | 39.16 | 49.04 |
Incannex Healthcare Inc is a clinical stage pharmaceutical company developing medical cannabis products for the treatment of Obstructive Sleep Apnea (OSA), Traumatic Brain Injury (TBI)/Concussion, Rheumatoid Arthritis, Inflammatory Bowel Disease, and Inflammatory Lung Conditions. The company has an Australian license to import, export, and distribute medicinal cannabis products and has launched a line of cannabinoid products. The Company operates and manages its business as one reportable and operating segment, which is the Research and Development of the use of psychedelic medicine and therapies.
Royalty Management Holding Corp formed to invest or purchase assets that have current or near-term income to provide the company with accretive cash flow from which it can reinvest in new assets or expand cash flow from existing assets. These assets typically are natural resources assets (including real estate and mining permits), patents, intellectual property, and emerging technologies.